Europe Next-generation Sequencing Market worth $8.88 billion by 2030
The report "Europe Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2030", is projected to reach USD 8.88 billion by 2030 from USD 4.42 billion in 2025, at a CAGR of 15.0% during the forecast period of 2025 to 2030.
Browse 400 market data Tables and 40 Figures spread through 350 Pages and in-depth TOC on "Europe Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-next-generation-sequencing-market-44130561.html
Several factors are fueling the expansion of the Europe next-generation sequencing market. The rising burden of cancer and other chronic and rare diseases, advances in precision and genomic medicine, and increasing public and private investment in sequencing infrastructure and large-scale national genomic initiatives are key growth drivers. Demand for personalized treatment options and earlier, more accurate diagnoses is driving the adoption of NGS across oncology, rare disease, reproductive health, and infectious disease testing. Meanwhile, the maturation of multiomics, advanced bioinformatics, and AI-based analytics is further supporting the adoption of high-throughput sequencing platforms and services across Europe.
The products segment accounted for the dominant share in 2024.
By offering, the Europe next-generation sequencing market is segmented into products and services. In 2024, the products segment held a leading market share, supported by a large installed base of sequencers across Europe's university hospitals, reference labs, and biopharma R&D centres, which drives steady demand for high-value reagents and library preparation kits. These products are critical for running targeted panels, whole-exome, and whole-genome sequencing with consistent quality and throughput.
The sequencing segment is estimated to be the largest and register the highest CAGR from 2025 to 2030 in the Europe next-generation sequencing products market.
By workflow, the Europe next-generation sequencing products market is divided into sequencing, pre-sequencing, and data analysis. The sequencing segment comprises products such as high-throughput instruments, flow cells, and sequencing reagent kits, capturing the largest share due to their key role in generating primary genomic data across clinical and research applications. Sequencing products benefit from high installed-base utilization, frequent consumable replenishment, and ongoing upgrades in platform throughput, read accuracy, and run flexibility, which are required for applications such as oncology panels, whole-genome sequencing, and microbial and agricultural genomics.
Germany is likely to be the fastest-growing country in the Europe next-generation sequencing market during the forecast period.
Germany is expected to grow at a faster rate than other countries in the Europe next-generation sequencing market. By country, the Europe next-generation sequencing market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany is a significant growth driver, due to robust government spending on the application of genomic medicine, an established infrastructure in university hospitals, and the presence of comprehensive cancer institutes that are actively implementing whole-genome sequencing within the community. The widespread adoption of NGS in oncology, rare disease diagnosis, and translational research, along with a robust pharmaceutical R&D community, are some factors contributing to a high number of tests in the Europe NGS markets. Additionally, a rising infrastructure in molecular pathology, an encouraging environment for innovation, and collaboration between academia, industry, and the government are making Germany grow at the highest rate within the European markets for NGS.
Prominent players operating in the European next-generation sequencing market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), and F. Hoffmann-La Roche (Switzerland), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Europe Next-generation Sequencing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
